Class Action Lawsuit Filed Against Medpace Holdings (NASDAQ: MEDP) Over Alleged Securities Fraud
A class action lawsuit has been filed against Medpace Holdings, Inc., alleging securities fraud and other unlawful business practices. The case follows the company's February 2026 earnings report that revealed a book-to-bill ratio of 1.04 below guidance, causing its stock price to drop by 15.9%. Investors who purchased shares during the class period are advised to contact Pomerantz LLP.
Tickers: $MEDP
Topics: class action earnings report securities fraud stock price drop